METRONOMIC ORAL CYCLOPHOSPHAMIDE IN THE SALVAGE TREATMENT OF HEAVILY TREATED OVARIAN CANCER PATIENTS: A RETROSPECTIVE, MULTICENTER STUDY

被引:0
|
作者
Corrado, G. [1 ]
Mascilini, F. [2 ]
Savarese, A. [3 ]
Samaritani, R. [4 ]
Salutari, V. [2 ]
Di Stefano, M. [2 ]
Malaguti, P. [3 ]
Vizza, E. [1 ]
Scambia, G. [2 ]
Ferrandina, G. [2 ]
机构
[1] Regina Elena Inst Canc Res, Gynecol Oncol Unit, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Gynecol Oncol Unit, I-00168 Rome, Italy
[3] Regina Elena Inst Canc Res, Med Oncol Unit, Rome, Italy
[4] Regina Margherita Hosp, Med Oncol Unit, Rome, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Immunological Effects of Metronomic Cyclophosphamide in Cancer Patients Treated with Oncolytic Adenoviruses
    Cerullo, Vincenzo
    Pesonen, Sari
    Diaconu, Iulia
    Escutenaire, Sophie
    Raki, Mari
    Ahtiainen, Laura
    Holm, Sirkka-Liisa
    Kanerva, Anna
    Kangasniemi, Lotta
    Haavisto, Elina
    Oksanen, Minna
    Laasonen, Leena
    Karioja-Kallio, Aila
    Ugolini, Matteo
    Arstila, Petteri T.
    Hemminki, Akseli
    MOLECULAR THERAPY, 2009, 17 : S246 - S246
  • [32] Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study
    Asmane, Irene
    Kurtz, Jean-Emmanuel
    Bajard, Agathe
    Guastalla, Jean-Paul
    Meeus, Pierre
    Tredan, Olivier
    Galy, Intidhar Labidi
    Moullet, Isabelle
    Ardisson, Philippe
    Vincent, Lionel
    Coeffic, David
    Dufresne, Armelle
    Bergerat, Jean-Pierre
    Ray-Coquard, Isabelle
    BULLETIN DU CANCER, 2011, 98 (09) : E80 - E89
  • [33] Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis
    Sharma, Aparna
    Malik, Prabhat Singh
    Khurana, Sachin
    Kumar, Sunesh
    Bhatla, Neerja
    Ray, M. D.
    Kumar, Lalit
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 150 (06) : 575 - 583
  • [34] Oral metronomic administration of cyclophosphamide and vinorelbine in previously treated patients with metastatic breast cancer: Phase II trial
    Pluma Jimenez, M. A.
    Perez, M.
    Bautista Aragon, Y. L.
    Villalobos, R.
    Rivera, S.
    Ortiz, K.
    Avila, G. G.
    Silva, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study
    Isono-Taniguchi, Roze
    Goto, Mayako
    Takimoto, Yumi
    Ueda, Tomoko
    Wakimoto, Yu
    Inoue, Kayo
    Hori, Kensuke
    Ito, Kimihiko
    Tsubamoto, Hiroshi
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 42
  • [36] Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer
    Chura, Justin C.
    Van Iseghem, Kelin
    Downs, Levi S., Jr.
    Carson, Linda F.
    Judson, Patricia L.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 326 - 330
  • [37] Triple combination of palliative oral metronomic chemotherapy in recurrent and metastatic epithelial ovarian cancer: A retrospective study
    Harsh, Kamlesh K.
    Jakhar, Shankar L.
    Maheshwari, Guncha
    Nirban, Rajkumar
    Kumari, Pramila
    Beniwal, Surender K.
    Sharma, Neeti
    Kumar, Harvindra S.
    INDIAN JOURNAL OF CANCER, 2023, 60 (02) : 167 - 172
  • [38] Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer
    Petrioli, Roberto
    Roviello, Giandomenico
    Fiaschi, Anna Ida
    Laera, Letizia
    Miano, Salvatora Tindara
    Marrelli, Daniele
    Roviello, Franco
    Bianco, Vincenzo
    Francini, Edoardo
    FUTURE ONCOLOGY, 2015, 11 (18) : 2563 - 2574
  • [39] Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study
    Feliu Batlle, J.
    Cuadrado, E.
    Castro, J.
    Caldes, T.
    Belda, C.
    Sastre, J.
    Barriuso, J.
    Martinez Marin, V.
    Diaz-Rubio, E.
    Gonzalez-Baron, M.
    CHEMOTHERAPY, 2011, 57 (02) : 138 - 144
  • [40] Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer
    Riccardo Samaritani
    Giacomo Corrado
    Enrico Vizza
    Carlo Sbiroli
    BMC Cancer, 7